73 related articles for article (PubMed ID: 20460050)
21. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
22. PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma.
Wang C; Xiao Y; Hu Z; Chen Y; Liu N; Hu G
FEBS Lett; 2008 Aug; 582(18):2793-8. PubMed ID: 18625225
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
24. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
25. [Adenovirus vector expressing MDA-7/IL-24 selectively induces growth arrests and apoptosis in human hepatocellular carcinoma cell lines independent of the state of p53 gene].
Xue XB; Zheng JW; Wang CJ; Chen K; Hu HY; Hu H; Yu Y; Wu ZD
Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):670-5. PubMed ID: 16995981
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
[TBL] [Abstract][Full Text] [Related]
27. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M
Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884
[TBL] [Abstract][Full Text] [Related]
28. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
29. Expression of the Musashi1 gene encoding the RNA-binding protein in human hepatoma cell lines.
Shu HJ; Saito T; Watanabe H; Ito JI; Takeda H; Okano H; Kawata S
Biochem Biophys Res Commun; 2002 Apr; 293(1):150-4. PubMed ID: 12054577
[TBL] [Abstract][Full Text] [Related]
30. [Expression of MAGE-A1 in human hepatoma cell lines associated with genic hypomethylation].
Xiao J; Chen HS; Fei R; Cong X; Wang Y; Jiang D; Wei L; Wang Y
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):351-4. PubMed ID: 15918969
[TBL] [Abstract][Full Text] [Related]
31. [Construction of recombinant plasmid human imprinted gene PEG10 and the primary functional identification in transfected cell lines].
Zhang Q; Xie N; Wang XY; Chang Y; Lin YY; Lin JS
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):287-90. PubMed ID: 17456318
[TBL] [Abstract][Full Text] [Related]
32. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
[TBL] [Abstract][Full Text] [Related]
33. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
34. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Kim JR; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
[TBL] [Abstract][Full Text] [Related]
37. Construction and identification of a human liver specific microRNA eukaryotic expression vector.
Chen S; Ni M; Yu B; Lv T; Lu M; Gong F
Cell Mol Immunol; 2007 Dec; 4(6):473-7. PubMed ID: 18163960
[TBL] [Abstract][Full Text] [Related]
38. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
[TBL] [Abstract][Full Text] [Related]
39. alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis.
Kawai HF; Kaneko S; Honda M; Shirota Y; Kobayashi K
Hepatology; 2001 Mar; 33(3):676-91. PubMed ID: 11230749
[TBL] [Abstract][Full Text] [Related]
40. Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma.
Martínez-Chantar ML; García-Trevijano ER; Latasa MU; Martín-Duce A; Fortes P; Caballería J; Avila MA; Mato JM
Gastroenterology; 2003 Apr; 124(4):940-8. PubMed ID: 12671891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]